A recent study showed that SMAD3−/−db/db mice do not exhibit cardiac dysfunction, myocardial inflammation or fibrosis, whereas SMAD3+/−db/db mice are not protected against cardiac pathology, which implies that SMAD3 plays a key role in the pathogenesis of DCM (166). This evidence concerns the gene SMAD3 and familial dilated cardiomyopathy.